跳至主要内容
临床试验/NCT02820259
NCT02820259已完成不适用

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

Rennes University Hospital1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2016年5月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
试验地点
1
主要终点
coefficient of correlation (r²) between the biliary concentration of TCR and concentration within PBMC

研究概览

简要总结

The purpose of this study is to demonstrate that the biliary concentration of TCR is a good marker of its immunosuppressive activity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (> 18 years) of both sexes,
  • Candidates for liver transplantation or retransplantation, whatever the etiology and severity of the underlying disease,
  • Not having expressed their opposition to participation in the study

排除标准

  • Bilio-enteric anastomosis,
  • Associated transplantation of another organ
  • Contraindications to TCR administration
  • Delayed introduction of TCR (beyond the 5th postoperative day) whatever the cause.

结局指标

主要结局

coefficient of correlation (r²) between the biliary concentration of TCR and concentration within PBMC

时间窗: during the first 7 days after its initiation

次要结局

未报告次要终点

研究者

发起方
Rennes University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验